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Background Although atrial fibrillation (AF) increases the risk of stroke, its relationship with atrial remodelling has not yet been
studied. We hypothesized that the degree of electroanatomical remodelling of the left atrium (LA) is related to
CHADS2/CHA2DS2VASc score and events of stroke.
Methods
and results
We compared CHADS2/CHA2DS2VASc score (0, 1, ≥2) or events of stroke with mean and regional LA volume
[by three-dimensional (3D) computed tomography images] or LA endocardial voltage (by 3D-electroanatomical
map) in 348 patients who underwent catheter ablation of AF (78.4% male, 55.4+11.0 years old, paroxysmal AF:per-
sistent AF ¼ 215:133). We graded LA volume index as Grade 1 (,48.3 mL/m2; n ¼ 80), grade 2 (48.3–63.0 mL/m2,
n ¼ 82), grade 3 (63.0–99.0 mL/m2; n ¼ 94), and grade 4 (≥99.0 mL/m2; n ¼ 92). Results (i) The percentage volume
of anterior portion of LA enlarged at the early stage of LA remodelling (Grade 1 vs. grade 2, P ¼ 0.006) and the
voltage of posterior venous LA was significantly reduced with the degree of LA remodelling (P ¼ 0.001). (ii) Mean
LA volume/body surface area (BSA), especially anterior portion of LA, was greater in patients with high CHADS2/
CHA2DS2VASc score (P ¼ 0.002). Mean LA voltage was significantly lower in patients with high CHA2DS2VASc
score than low score (P ¼ 0.007). (iii) In patients who experience stroke (n ¼ 22), LA volume/BSA, especially
anterior LA, was greater (P ¼ 0.012), and LA endocardial voltage was lower (P ¼ 0.039) than those without stroke.
Conclusion Electroanatomical remodelling of LA, estimated by LA volume and endocardial voltage, has significant relationship
with the risk scores or events of stroke in patients with non-valvular AF.
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Introduction
Atrial fibrillation (AF) is the most common arrhythmia disorder,
affecting up to 9% of the population by the age of 80 years, and
is a significant risk factor for thromboembolic stroke.1,2 CHADS2
scores have been utilized as an excellent predictor of stroke and
a guideline for anti-thrombotic therapy in patients with non-
valvular AF.3–5 Although the CHADS2 score is an effective predic-
tor of ischaemic stroke in patients with AF, the pathophysiologic
mechanisms remain to be studied. Substrate or tissue factors
related to CHADS2 scores have to be considered. Recurrent fibril-
latory activation of AF induces progressive electrical and tissue
structural remodelling,6–8 and reduction of left atrial (LA) endo-
cardial voltage in the presence of fibrosis.9 We previously reported
that AF-related electroanatomical remodelling changes both
entire and regional LA volume, endocardial voltage, conduction
velocity, and distribution of complex fractionated atrial electro-
gram.10–12 However, the relationship between the degree of
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electroanatomical remodelling and CHADS2 score and the event
of stroke has not yet been studied. Therefore, we hypothesized
that the degree of electroanatomical remodelling of LA is related
to CHADS2 scores and to the event of stroke. The purposes of
this study were to evaluate the regional volume change of LA
depending on the degree of structural remodelling, and to
compare the degree of mean and regional LA volume enlargement
or LA endocardial voltage depending on CHADS2 score and the
events of stroke. We also compared the degree of electroanatomi-
cal remodelling with newly suggested risk scores for stroke in non-
valvular AF—CHA2DS2VASc score.
13
Methods
Patient selection
The study protocol was approved by the Institutional Review Board of
our institute. All patients provided written informed consent. The
study enrolled 348 patients with AF (male:female ¼ 273:75, mean
age ¼ 55.4+11.0 years old) who underwent radiofrequency catheter
ablation (RFCA). Among them, 215 patients had paroxysmal AF, and
133 had persistent AF (PeAF). The exclusion criteria were as
follows: (i) permanent AF refractory to the electrical cardioversion;
(ii) LA sizes .55 mm measured on echocardiogram; (iii) AF with rheu-
matic valvular disease; (iv) associated structural heart disease other
than left ventricular (LV) hypertrophy; (v) prior AF ablation; and
(vi) sinus rhythm not maintained for LA voltage mapping before
RFCA. The patients with the presence of an LA thrombus were
excluded by transoesophageal echocardiography. We imaged all
patients with a three-dimensional (3D) spiral computed tomography
(CT) (64 Channel, Light Speed Volume CT, Philips, Brilliance 63,
Amsterdam, Netherlands) to visually define the anatomy of LA and
pulmonary veins (PVs). Trans-thoracic echocardiography was per-
formed in every patient and LV systolic and diastolic functions were
measured by ejection fraction (EF) and mitral valve area tissue
Doppler (E/E’), respectively.
Electrophysiological mapping procedure
Intracardiac electrograms were recorded using the Prucka Cardi-
oLabTM Electrophysiology system (General Electric Medical Systems
Inc., Easton Turnpike, Fairfield, USA), and catheter ablation procedures
were performed on all patients using 3D electroanatomical mapping
(NavX, St Jude Medical Inc., Minnetonka, MN, USA) merged with 3D
spiral CT. Before catheter ablation, we generated an LA 3D electroa-
natomical map and a voltage map by obtaining contact bipolar electro-
grams from 350–400 points of the LA endocardium, during atrial
pacing with a pacing cycle length of 500 ms. Bipolar electrograms
were filtered from 32 to 300 Hz. Colour-coded voltage maps were
generated by recording bipolar electrograms and measuring
peak-to-peak voltage. The acquisition of an LA voltage map was aban-
doned if frequently re-initiating AF required electrical cardioversion
more than three times. Only patients for whom the LA voltage map
was available were included in the study.
Figure 1 (A) Right lateral views of left atrium in the reconstructed three-dimensional spiral computed tomography image depending on the
degree of left atrial remodelling. (B) left atrium images were divided into the venous atrium, the anterior left atrium, and the left atrial appen-
dage. Volumetric measurement reveals significantly higher relative volume of the anterior left atrium in Stage 2 remodelling than in Stage 1.
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Volumetric and curvilinear analyses
of three-dimensionalspiral computed
tomography imaging
The 3D spiral CT images of LA were analysed on an imaging processing
workstation (Aquarius, Terarecon Inc., San Mateo, CA, USA) as
described before.11 The curvilinear lengths on LA were measured at
the linear ablation sites: bilateral antral ablation line, roof line, posterior
inferior line, left lateral isthmus line, anterolateral line, and anteroseptal
line. Each LA image was divided into portions by embryological origin
as follows: the venous LA (posterior LA including the antrum and
posterior wall), LA appendage (LAA), and anterior LA (excluding the
LAA and venous LA).14 Although both LAA and anterior LA are
embryologically of primordial atrial origin, they differ in geometry,
myocardial fibre orientations, and distribution of autonomic inner-
vations. Therefore, we divided LAA and anterior LA, and referenced
them to the points of inflection on the 3D spiral CT image. The absol-
ute and relative volumes of each portion were calculated and
compared.
Off-line analyses of colour-coded
three-dimensional maps of left atriums
We analysed colour-coded voltage maps of both anterior–posterior
(AP) and posterior–anterior views that had been converted to
image files as previously reported.11 PVs were not included in the
analysis. The digital measurements of colour-coded voltage maps
were performed by a single student, using a consistent method, who
was blinded to the clinical information of the maps. The percentage
of colour-coded areas in each quadrant of the voltage maps was ana-
lysed by customized software (Image Pro, Silver Spring, MD, USA), and
referenced to the colour scale bars. NavX detected peak-to-peak
voltage differences of each contact bipolar electrogram, and changed
them to colour codes. Low-voltage areas, defined as LA voltage
≤0.2 mV, were coded grey; high-voltage areas (.5.0 mV) were
coded purple. The mean LA voltage was calculated by summation of
% area of each colour multiplied by representative voltage, and then
divided by the total area of LA. The reference distance was measured
by the inter-electrode distances of coronary sinus catheters (duodeca-
polar catheter, St Jude Medical Inc.).
Data analyses
We classified patients according to CHADS2 scores (0, n ¼ 154; 1,
n ¼ 124; and ≥2, n ¼ 70), CHA2DS2VASc score (0, n ¼ 146; 1,
n ¼ 106; and ≥2, n ¼ 96), the quartiles of 3D spiral CT measured LA
volume index (Grade 1≤48.3 mL/m2, n¼ 87; Grade 2, 48.3–63.0 mL/m2,
n ¼ 87; Grade 3, 63.0–99.0 mL/m2, n ¼ 87; and Grade 4 ≥ 99.0 mL/m2,
n ¼ 87), and the patients with (n ¼ 22) or without (n ¼ 326) stroke.
We compared them by absolute or relative volumes or curvilinear
lengths adjusted by BSA, mean LA voltage, LV systolic and diastolic func-
tion, and duration of AF. Data are expressed as the mean+standard
deviation. The statistical significance of these comparisons was assessed
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Table 1 Comparison ofleft atrial morphology and left ventricular function according to atrial fibrillation -related left
atrial size
Grade 1 Grade 2 Grade 3 Grade 4 ANOVA ANOVA
(n 5 87) (n 5 87) (n 5 87) (n 5 87) P value Power
LA volumes (mL)
Entire LA volume 74.9+13.7 101.2+12.1* 128.2+13.7**† 170.8+36.4§‡[] P, 0.001 1
Anterior LA volume 42.4+10.5 60.6+12.8* 78.6+11.2**† 104.4+28.7§‡[] P, 0.001 1
Venous LA volume 26.1+8.2 32.3+6.6* 38.8+8.2**† 52.4+15.0§‡[] P, 0.001 1
LAA volume 6.5+3.1 8.7+3.3 10.8+3.6**† 14.0+5.4§‡[] P, 0.001 1
Relative volumes of regional LA (%)
Anterior LA volume 56.4+8.5 59.5+7.5 61.3+5.4** 60.7+8.0§ P, 0.001 0.979
Venous LA volume 34.9+8.4 31.9+7.4 30.2+5.3** 31.0+7.5§ P, 0.001 0.974
LAA volume 8.7+3.9 8.6+3.2 8.5+3.1 8.3+2.8 P ¼ 0.797 0.094
LA voltage (mV)
Mean LA voltage 1.6+0.8 1.4+0.6 1.3+0.6 1.0+0.6§ P ¼ 0.002 0.873
Anterior LA voltage 1.4+0.6 1.2+ .0.6 1.3+0.6 0.9+0.6§ P ¼ 0.034 0.878
Venous LA voltage 1.8+1.3 1.0+0.9* 1.1+1.0** 0.8+0.8§ P ¼ 0.001 1
LAA voltage 3.1+1.7 2.8+1.5 2.5+1.6 2.0+1.3§ P ¼ 0.018 0.708
LV function
LVEF (%) 61.0+7.2 60.9+7.4 60.1+8.2 57.2+10.8§‡ P ¼ 0.012 0.806
E/E’ 8.5+2.6 9.2+3.6 9.7+4.1 10.6+4.4§ P ¼ 0.014 0.781
Hypertension 26 (29.9 %) 38 (43.7 %) 47 (54.0 %)** 45 (51.7 %)§ P ¼ 0.005 1
Renal insufficiency 2 (2.3 %) 1 (1.1 %) 2 (2.3 %) 1 (1.1 %) P ¼ 0.880 1
Recurrence 11 (12.6 %) 11 (12.6 %) 16 (18.4 %) 24 (27.6 %)§ P ¼ 0.005 1
BSA, body surface area; LAA, LA appendage; LV, left ventricle; EF, ejection fraction, ANOVA, analysis of variance.
*P, 0.05, Grade 1 vs. Grade 2, **P, 0.05, Grade 1 vs. Grade 3, §P, 0.05, Grade 1 vs. Grade 4, †P, 0.05, Grade 2 vs. Grade 3, ‡P, 0.05, Grade 2 vs. Grade 4, []P, 0.05,
Grade 3 vs. Grade 4.
CHADS2 score and atrial remodelling 1543
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on N
ovem
ber 10, 2013
http://europace.oxfordjournals.org/
D
ow
nloaded from
 
using the Student t-test and analysis of variance (ANOVA) test. A P value
of ,0.05 was considered statistically significant.
Results
Enlargement of the anterior portion of
left atrium in the early stages of left atrial
remodelling
Figure 1 displays the right anterior oblique views of 3D spiral CT
image of LA in each grade of remodelling. In Grade 2 LA remodel-
ling, the anterior portion of the LA was remarkably enlarged, and
the AP diameter of LA prolonged significantly. In contrast, the pos-
terior venous LA and LAA were proportionally enlarged at Grade
3–4 of LA remodelling. Table 1 summarizes LA volumes, regional
lengths, endocardial LA voltage, LV functions, and recurrence.
The proportion of relative volumes of anterior LA was significantly
greater (P, 0.001), but posterior venous LA was smaller
(P , 0.001) in patients with high-grade remodelling than those
with low-grade remodelling (Figure 2A). The increase in relative
anterior LA volume was more significant in Grade 2 than in
Grade 1 remodelling (P ¼ 0.006, Figure 2A). Left atrial endocardial
voltage was generally reduced more in patients with high-grade
remodelling than in those with low-grade remodelling
(P ¼ 0.002), and it was most significant in venous LA (P ¼ 0.001,
Figure 2D).
Greater left atrial volume in patients
with higher CHADS2 score
We compared mean and regional LA volumes in terms of CHADS2
score (0, n ¼ 154; 1, n ¼ 124; and ≥2, n ¼ 70; Table 2) and CHA2-
DS2VASc score (0, n ¼ 146; 1, n ¼ 106; and ≥2, n ¼ 96; Table 3).
Mean LA volume/BSA was significantly higher in patients with high
CHADS2 score (P ¼ 0.002, Figure 2B), and this difference was sig-
nificant especially in the regional volume of the anterior portion of
LA (P ¼ 0.048, Table 2). The proportions of PeAF were 34.4% in
CHADS2 score 0, 40.3% in CHADS2 score 1, and 42.9% in
CHADS2 score ≥2 (P ¼ NS). In addition, EF was significantly
lower (P ¼ 0.005), E/E’ was higher (P ¼ 0.002), and the pro-
portions of hypertension (P, 0.001) and renal insufficiency (P ¼
0.016) were higher in patients with higher CHADS2 score than
those with lower CHADS2 score in ANOVA analyses (Table 2).
When we compared depending on CHA2DS2VASc score
(Table 3), these findings were consistent with the CHADS2
scores, and LA volume/BSA was significantly higher in patients
with high CHA2DS2VASc scores (Figure 2C). In the analyses of
LA endocardial voltage, the mean and regional endocardial vol-
tages tended to be lower in patients with high CHADS2 score
LA volume/BSA (CHADS2 Score)Relative Regional Volume of LA LA volume/BSA (CHA2DS2VASc Score)(mL/m2) p=0.002(%) (mL/m2)100 p=0.002
80
p=0.008* p=0.002
60
p<0.001
p=0.021* p=0.00740
20
LA
0
100
80
60
40
20
0
100
80
60
40
20
0
Anterior
LA
Venous
LA
LA
appendage
Anterior
LA
Venous
LA
LA
appendage
LA Anterior
LA
Venous
LA
LA
appendage
LA Anterior
LA
Venous
LA
LA
appendage
LA Anterior
LA
Venous
LA
LA
appendage
LA Anterior
LA
Venous
LA
LA
appendage
Mean LA Voltage (CHA2DS2VASc Score) Mean LA Voltage (CHADS2 Score)Mean LA Voltage (mV)(mV)(mV)
6.0 6.06.0
5.0 5.0
p=0.004
5.0
4.0 4.04.0
3.0 3.03.0 p=0 007
p=0.013
p=0 016
p=0.009
2.02.0
.
p=0.039
.
2.0
1.0 1.01.0
0.0 0.00.0
p<0.001
Grade I
Grade II
Grade III
Grade IV
Grade I
Grade II
Grade III
Grade IV
CHADS2 Score 0
CHADS2 Score 1
CHADS2 Score ≥2
CHADS2 Score 0
CHADS2 Score 1
CHADS2 Score ≥2
CHA2DS2VASc Score 0
CHA2DS2VASc Score 1
CHA2DS2VASc Score ≥2
CHA2DS2VASc Score 0
CHA2DS2VASc Score 1
CHA2DS2VASc Score ≥2
A B C
D E F
Figure 2 In high-grade remodelled left atrium, portion of anterior left atrium (A) was significantly larger, mean left atrium voltage (D) was
significantly lower than those low-grade remodelled left atrium. In higher CHADS2 score, left atrium volume/body surface area (B) was signifi-
cantly larger; left atrium voltage (E) was lower than those lower CHADS2 score. In higher CHA2DS2VASc score, left atrium volume/body
surface area (C) was significantly larger; left atrium voltage (F) was significantly lower than in the case of lower CHADS2 score.
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than in those with low scores (Figure 2E), but it was significant in
terms of CHA2DS2VASc score (P ¼ 0.007, Figure 2F).
Low left atrial endocardial voltage and
higher anterior left atrial volume in
patients with stroke
Figure 3A and B display the representative examples of CT-merged
LA voltage maps, and the patients who experienced stroke show
low endocardial voltage with enlarged LA volume in comparison
with the patient without stroke. We compared them with 326
patients without stroke and summarized this in Table 4. There
were 22 patients who experienced episodes of stroke in this
study. The stroke occurred 18.2+18.4 months before catheter
ablation, and CHADS2 score was 3.2+0.2 at that time. The
type of stroke was ischaemic embolic stroke in all 22 patients,
but haemorrhagic transformation occurred during stroke manage-
ment in 2 patients. In patients who had experienced a previous
stroke, mean LA volume/BSA (P ¼ 0.012), especially anterior LA
(P ¼ 0.006), was significantly enlarged, and mean LA endocardial
voltage (P ¼ 0.039), especially venous LA voltage (P ¼ 0.005),
was significantly lower than those without stroke (Figure 3C
and D). In the uni-variate analyses (t-test), LA diameter (P ¼
0.011), left ventricular ejection fraction (LVEF; P ¼ 0.041),
CHADS2 score (P, 0.001), LA volume/BSA (P ¼ 0.026), LAA
volume% (P ¼ 0.012), anterior LA volume% (P ¼ 0.025), and LA
voltage (P ¼ 0.039) were related with the event of stroke. In the
multi-variate regression analysis, the factor most related to the
episode of stroke was CHADS2 score (OR ¼ 3.641, CI 2.033–
6.521, P, 0.001) among them.
Discussion
This is the first study that reports on the relationship between the
degree of electroanatomical remodelling of LA and the risk or
events of stroke in patients with non-valvular AF. We also eluci-
dated disproportional enlargement of the anterior portion of LA
in the early stages of structural remodelling and its relationship
with CHADS2 score, and low endocardial voltage of posterior
venous atrium in patients with stroke. Therefore, CHADS2 score
represents not only a clinical risk factor for ischaemic stroke, but
is also related to atrial substrates for thoromboembolism in
patients with AF.
Risks scores and potential mechanisms
of stroke in patients with non-valvular
atrial fibrillation
Atrial fibrillation causes a five-fold increase in the risk of ischae-
mic stroke or transient ischaemic attack (TIA).15 CHADS2 score
is a risk stratification scheme for ischaemic stroke in patients with
non-valvular AF based on the presence of heart failure,
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Comparison of left atrial morphology and left ventricular function according to atrial fibrillation -related
CHADS2 score
CHADS2 score 0 CHADS2 score 1 CHADS2 score ≥2 ANOVA ANOVA
(n5 154) (n 5 124) (n5 70) P value POWER
LA volumes/BSA (mL/m2)
Entire LA volume 57.4+23.9 64.3+28.1 69.8+21.9** P ¼ 0.002 0.882
Anterior LA volume 34.7+17.5 38.4+19.4 42.7+14.4** P ¼ 0.008 0.797
Venous LA volume 18.7+7.9 20.9+8.2 21.5+8.9 P ¼ 0.021 0.671
LAA volume 5.3+2.5 5.6+2.9 5.6+2.5 P ¼ 0.520 0.140
Relative volumes of regional LA (%)
Anterior LA volume 58.3+8.6 60.3+6.5 60.5+7.1 P ¼ 0.048 0.599
Venous LA volume 32.9+6.9 31.2+6.9* 31.3+6.3 P ¼ 0.111 0.444
LAA volume 8.7+3.3 8.5+3.2 8.2+3.3 P ¼ 0.555 0.142
LA voltage (mV)
Mean LA voltage 1.4+0.8 1.4+0.6 1.2+0.5 P ¼ 0.110 0.288
Anterior LA voltage 1.3+0.6 1.2+0.6 1.1+0.6 P ¼ 0.285 0.292
Venous LA voltage 1.3+1.2 1.2+1.0 0.9+0.7 P ¼ 0.080 0.388
LAA voltage 2.9+1.8 2.6+1.4 2.2+1.3 P ¼ 0.077 0.493
LV function
LVEF (%) 61.2+5.9 57.9+9.5* 59.4+10.7 P ¼ 0.005 0.817
E/E’ 8.9+3.3 9.4+3.4 10.3+5.0** P ¼ 0.002 0.535
Hypertension 0 (0.0 %) 99 (79.8 %)* 57 (81.4 %)** P, 0.001 1.000
Renal insufficiency 1 (0.6 %) 1 (2.4 %) 4 (5.7%)** P ¼ 0.016 1.000
Recurrence 23 (14.9 %) 30 (24.2 %)* 9 (12.9 %) P ¼ 0.359 0.882
BSA, body surface area; LAA, LA appendage; LV, left ventricle; EF, ejection fraction, ANOVA, analysis of variance.
*P, 0.05, CHADS2 score 0 vs. CHADS2 score 1, **P, 0.05, CHADS2 score 0 vs. CHADS2 score ≥2.
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hypertension, age .75 years old, diabetes, previous stroke, or
TIA.16 The 2006 version of the American College of Cardiol-
ogy/American Heart Association Task Force on Practice Guide-
lines/European Society of Cardiology Committee for Practice
(ACC/AHA/ESC) practical guidelines for AF recommends war-
farin or aspirin for patients depending on their CHADS2
score.5 Recently, European Society of Cardiology have suggested
new guidelines for AF management,13 and proposed a CHA2DS2-
VASc score that strengthens the importance of age, sex, and
combined vascular disease as risk factors for ischaemic stroke
in addition to CHADS2 score. Although both CHADS2 and
CHA2DS2VASc scores are effective predictors for ischaemic
stroke, their pathophysiologic mechanisms remain to be clarified.
Atrial contractile remodelling and blood stasis in LA during AF
has generally been considered to be a major mechanism of thor-
omboembolism in patients with AF.17–19 Blood stasis or hyper-
coagulable states are major contributors for thrombogenesis,
but tissue factors cannot be underestimated. CHADS2 score
and CHA2DS2VASc score include risk factors related to vascular
remodelling, metabolic syndrome, change of cardiac substrates, or
tissue factors. The degree of electroanatomical remodelling of AF
is closely related with myocardial fibrosis,20,21 matrix remodelling,
and angiotensin II-NADPH oxidase-mediated thrombus for-
mation.22 In this study, we demonstrated the relationship
between LA volume/endocardial voltage and risk scores or
events of stroke in patients with AF.
Electroanatomical remodelling process
in atrial fibrillation
The mechanisms for LA remodelling include pressure or volume
overload to LA by LV dysfunction, deranged plasma volume
control, intensified neurohormonal activation, or atriomyopathy
itself.23 In this study, the anterior portion of the LA was enlarged
in the early stages of LA remodelling, and the potential mechanisms
are as follows: first, haemodynamic overload may stretch thin the
traveculated wall of the anterior portion of LA early by Laplace’s
law. Secondly, the posterior venous LA and the anteroseptum
abut the fixed rigid structures, the spine, and the ascending
aorta, respectively. Therefore, LA volume increased antero-
laterally and the volume of anterior LA was enlarged in the early
phases of remodelling.
The presence of fibrosis/low-voltage tissue has been postulated
as a potential cause of abnormalities in atrial activation that may
underlie the initiation and maintenance of fibrillation.24,25 The
degree of voltage reduction may help grade the severity of tissue
pathology underlying AF before and after catheter ablation.26
Increased fibrosis has also been clearly demonstrated in human
LA tissue specimens of patients with AF,20,21 and correlations
have been observed between serum markers of atrially selective
fibroblasts and clinical AF.27 We also previously reported that
low endocardial voltage of LA is closely related to LA volume
remodelling,11 reduced conduction velocity,10 and the patterns of
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Comparison of left atrial morphology and left ventricular function according to atrial fibrillation-related
CHADS2VASc score
CHA2DS2VASc score 0 CHA2DS2VASc score 1 CHA2DS2VASc score ≥2 ANOVA ANOVA
(n5 146) (n5 106) (n5 96) P value POWER
LA volumes/BSA (mL/m2)
Entire LA volume 57.1+26.4 63.5+24.4 68.8+23.7** P ¼ 0.002 0.885
Anterior LA volume 34.8+19.6 36.6+16.0 42.8+15.9**† P ¼ 0.002 0.873
Venous LA volume 18.4+8.0 20.7+7.9* 21.7+8.7** P ¼ 0.007 0.810
LAA volume 5.2+2.4 5.6+2.8 5.7+2.7 P ¼ 0.256 0.269
Relative volumes of regional LA (%)
Anterior LA volume 58.3+8.5 59.6+6.9 61.1+6.8** P ¼ 0.019 0.701
Venous LA volume 33.0+8.3 31.8+6.8 30.7+6.6 P ¼ 0.050 0.553
LAA volume 8.7+3.3 8.6+3.1 8.2+3.4 P ¼ 0.525 0.170
LA voltage (mV)
Mean LA voltage 1.5+0.8 1.3+0.5 1.2+0.5** P ¼ 0.007 0.587
Anterior LA voltage 1.3+0.6 1.2+0.5 1.1+0.6** P ¼ 0.039 0.332
Venous LA voltage 1.5+1.3 1.1+0.8 0.9+0.7** P ¼ 0.013 0.816
LAA voltage 3.1+1.8 2.5+1.4 2.2+1.3** P ¼ 0.004 0.811
LV function
LVEF (%) 60.6+6.9 57.3+9.8* 61.5+9.0† P ¼ 0.001 0.924
E/E’ 9.0+3.4 8.8+3.2 11.0+4.5**† P, 0.001 0.968
Hypertension 0 (0.0 %) 80 (75.2 %)* 76 (79.2 %)** P, 0.001 1.000
Renal insufficiency 0 (0.0 %) 2 (1.9 %) 4 (4.2 %) P ¼ 0.051 1.000
Recurrence 24 (16.4 %) 21 (19.8 %)* 17 (17.7 %) P ¼ 0.683 1.000
BSA, body surface area; LAA, LA appendage; LV, left ventricle; EF, ejection fraction, ANOVA, analysis of variance.
*P, 0.05, CHADS2 score 0 vs. CHADS2 score 1, **P, 0.05, CHADS2 score 0 vs. CHADS2 score ≥2, †P, 0.05, CHADS2 score 1 vs. CHADS2 score ≥2.
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complex fractionated atrial electrograms in AF.12 In this study, the
degree of electroanatomical remodelling of LA was directly related
to the risk or events of stroke in patients with AF. Further studies
by non-invasive imaging methods, such as fibrosis on magnetic res-
onance imaging or stain on echocardiography, will characterize the
degree of LA remodelling anatomically and functionally.28
Clinical implication of left atrial structural
remodelling
Electroanatomical remodelling of the atria has been known to be a
predictor of AF recurrence after cardioversion29 or RFCA,11,30 and
a risk of stroke, as shown in this study. Therefore, more strict
anti-coagulation is warranted in those patients with low-voltage
scars and enlarged LA. Longer duration of RF energy delivery is
more of a necessity for effective rhythm control in AF patients
with remodelled atria than for those with less remodelled atria.
However, the operator should keep in mind that profuse RF abla-
tion can increase LA scar or atriomyopathy,26 and might raise the
risk of stroke by electroanatomical remodelling. Whether reverse
remodelling and LA voltage occurs after successful catheter abla-
tion of AF is unclear. The appropriate strategy for anti-coagulation
after abolishing AF remains to be studied. New drugs31,32
or devices33 provide more options for AF management, and
customized guidelines will be required according to the symptoms,
haemodynamic factors, and risks of stroke.
Study limitations
The patients included in this study were a highly selective group
referred for RFCA, and the number of patients was also limited.
We also excluded patients with LA size of .50 mm. Because
we acquired voltage maps via point-by-point contact mapping,
the maps did not reflect a spatiotemporally homogeneous distri-
bution. We analysed 3D voltage maps using 2D measurements.
Although we strictly followed ACC/AHA/ESC guideline based on
the CHADS2 score,
5 we do not have data of the anti-thrombotic
regimen at the time of ischaemic stroke because most patients
included in this study were referred patients for catheter ablation.
The patient group in this study was highly selected patients with
relatively small LA volume with low risk of stroke. Therefore,
the result of this study may not be extrapolated to the patients
with permanent AF and significant LA remodelling.
Conclusion
We documented different patterns of CHADS2 score in patients
with structurally remodelled LA. In patients with non-valvular AF,
LA volume was larger in patients with high CHADS2 score than
LA voltage (No Stroke) LA voltage (Stroke)
BA
10 mV
5 mV
20 00 /di20 00 /di0 mV .  mm v.  mm v
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Figure 3 Anterior and posterior views of colour-coded left atrium voltage map during ablation. (A) High left atrium voltage in patients
without stroke. (B) Low left atrium voltage in patients with stroke. In patients with stroke, mean left atrium volume and relative regional
volume of anterior left atrium were larger (C), and mean left atrium voltage and regional left atrium voltage of venous atrium were lower
(D) than those without stroke.
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those with low CHADS2 score and LA voltage was lower in
patients with stroke. Thus, stroke risk factors may be related to
the degree of electroanatomical remodelling of LA and anterior
LA might play a role in the early phase of structural remodelling
in patients with AF.
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A case of atrioventricular nodal reentrant tachycardia with high take-off
coronary sinus
Seigo Yamashita , Teiichi Yamane*, and Michihiro Yoshimura
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A 73-year-old female with atrioventricular nodal reentrant tachycardia (AVNRT) presented with high-takeoff coronary sinus (CS).
Coronary sinus venography revealed that the CS ostium was located at an unusual site where the His-bundle is supposed to be
located (arrows in Figure 1A and B), and the successful ablation site for the slow pathway was located below the CS ostium
(Figures 1A–C). This patient was treated by slow-pathway ablation using only the electrophysiological approach. Therefore, slow
pathway ablation for AVNRT should not be guided by only anatomical approaches in cases with an anomaly of the CS.
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Figure 1 Radiographs demonstrating high-takeoff CS, and intracardiac electrogram.
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